Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials

BackgroundOverweight and obesity are increasing global public health problems. Mazdutide is a new dual agonist drug that can potentially reduce weight and blood glucose levels simultaneously. However, the synthesis of evidence on the efficacy and safety of this drug is scarce. Therefore, this study...

Full description

Bibliographic Details
Main Authors: David Lubasi Nalisa, Nelson Cuboia, Eman Dyab, Idongesit Linus Jackson, Habimana Jean Felix, Pantaleon Shoki, Mary Mubiana, Mariam Oyedeji-Amusa, Luís Azevedo, Hongwei Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Endocrinology
Subjects:
dual agonist-receptor
IBI362
diabetes
Mazdutide
obesity
overweight
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1309118/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2024.1309118/full

Similar Items